ASX Runners: Zelira, Linq, Dalaroo & Osteopore Lead Gains
Zelira Therapeutics rockets 184% on $50m autism drug deal, while Linq Minerals and Dalaroo Metals surge on gold, copper and Greenland rare earths. Discover the week's top ASX performers.
Category : Search result: Osteopore
Page 1 of 1